Irreversible binding of cisplatin in rat serum

Pharmacy and Pharmacology Communications

Volumn 5, Issue 7, 1999, Pages 449-453

  Takada, Kanji ^a   Kawamura, Tomonori ^a   Inai, Maya ^a   Yoshikawa, Yukako ^a   Osamu, Ike ^b   Wada, Hromi ^b   Hitomi, Shigeki ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; BENZYLSULFONYL FLUORIDE; CISPLATIN;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; DIALYSATE; DIALYSIS; DRUG BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SERUM;

EID: 0032772801     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128735153     Document Type: Article

References (19)

1. Aull, J. L., Allen, R. L., Bapat, A. R., Daron, H. H., Friedman, M. E., Wilson, J. F. (1979) The effects of platinum complexes on seven enzymes. Biochim. Biophys. Acta 571: 352-358
2. Bischer, A., Zia-Amirhosseini, P., Iwaki, M., McDonagh, A. F., Benet, L. Z. (1995) Stereoselective binding properties of naproxen glucuronide diastereomers to proteins. J. Pharmacokin. Biopharm. 23: 379-395
3. Cole, W. C., Wolf, W. (1980) Preparation and metabolism of a cisplatin/serum protein complex. Chem. Biol. Interact. 30: 223-235
4. Daley-Yates, P. T., McBrien, D. C. H. (1985) The renal fraction clearance of platinum antitumour compounds in relation to nephrotoxicity. Biochem. Pharmacol. 34: 1423-1428
5. Eastman, A. (1996) Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy: Part 2. Plenum Press, New York, pp 283-291
6. Forastiere, A. A., Takasugi, B. J., Baker, S. R., Wolf, G. T., Kudla-Hatch, V. (1987) High-dose cisplatin in advanced head and neck cancer. Cancer Chemother. Pharmacol. 19: 155-158
7. Gullo, J. J., Litterst, C. L., Maguire, P. J., Sikic, B. I., Hoth, D. F., Woolley, P. V. (1980) Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother. Pharmacol. 5: 21-26
8. Hanada, K., Nagai, N., Ogata, H. (1995) Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography. J. Chromatogr. B 663: 181-186
9. Ivanov, A. I., Christodoulou, J., Parkinson, J. A., Kevin, J. B., Alan, T., John W., Peter, J. S. (1998) Cisplatin binding sites on human albumin. J. Biol. Chem. 273: 14721-14730
10. Kruidering, M., Water, B., Zhan, Y., Baelde, J. J., Heer, E., Mulder, G. J., Stevens, J. L., Fred, J. (1985) Cisplatin effects on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro. Cell Death Differ. 5: 601-614
11. Loehrer, P. J., Einhorn, L. H. (1984) Diagnosis and treatment drugs five years later. Ann. Intern. Med. 100: 704-713
12. Nagai, N., Ogata, H. (1996) The renal clearance of unchanged cisplatin during furosemide and mannitol diuresis is dependent on glomerular filtration rate in rats. J. Pharm. Sci. 85: 720-725
13. Nakano, K., Ike, O., Wada, H., Hitomi, S., Amano, Y., Ogita, I., Nakai, N., Takada, K. (1997) Oral sustained-release cisplatin preparation for rats and mice. J. Pharm. Pharmacol. 49: 485-490
14. Perera, F., Fischman, H. K., Hemminki, K., Brandt-Rauf, P., Niman, H. L., Smith, S., Toporoff, E., O'Dowd, K., Tang, M. X., Tsai, W. Y., Stoopler, M. (1990) Protein binding sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapy. Arch. Toxicol. 64: 401-406
15. Reed, E., Ozols, R. F., Tarine, R., Yuspa, S. H., Poirier, M. C. (1988) The measurements of cisDDP-DNA adduct levels in testicular cancer patients. Carcinogenesis 9: 1909-1911
16. Reed, E., Ostchega, Y., Steinberg, S. M., Yuspa, S. H., Young, R. C., Ozols, R. F., Poirier, M. C. (1990) Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients. Cancer Res. 50: 2256-2260
17. Reedijk, J. (1995) Handbook of Metal Ligand Interactions in Biological Fluids. Vol. 2. Marcel Dekker, New York, pp 967-989
18. Smith, P. C., McDonagh, A. F., Benet, L. Z. (1989) Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig. J. Pharmacol. Exp. Ther. 252: 218-224
19. Yotsuyanagi, T., Ohta, N., Futo, T., Ito, S., Chen, D., Ikeda, K. (1991) Multiple and irreversible binding of cis-diamminedichloroplatinum(II) to human serum albumin and its effect on warfarin binding. Chem. Pharm. Bull. 39: 3003-3006